_JIKK_2024-2.pdf_.png)
1.png){kind=logo}
.png)
.png)
.png)
.jpg)
A Case Report: Multidrug-Resistant Tuberculosis in A 53-Year-Old Patient
Sari
A 53-year-old man with multidrug-resistant tuberculosis (MDR-TB) presented with clinical symptoms such as cough with yellow-white sputum for a month, shortness of breath, fever, night sweats, and weight loss. After completing six months of TB treatment in 2010, he developed MDR-TB, proven by resistance to rifampicin. Initial diagnosis by chest X-ray showed signs of pulmonary TB and right pleural effusion, while the sputum test confirmed Mycobacterium tuberculosis with moderate bacterial load. Laboratory results showed anemia, leukocytosis, and hypoalbuminemia. The patient's therapy included a combination of bedaquiline, levofloxacin, linezolid, clofazimine, cycloserine, and vitamin B6, along with additional treatments such as antibiotics, symptomatic therapy, and nutritional support. The medical team conducted regular monitoring and consultation with pulmonary, psychiatry, and nutrition specialists to ensure treatment compliance. This case highlights the challenges in managing MDR-TB, especially in patients with a history of TB. Early detection of drug resistance and prompt implementation of appropriate therapy are essential to improve treatment outcomes and prevent further spread. This report emphasizes the need for a multidisciplinary approach and close monitoring in the management of MDR-TB.
Kata Kunci
Teks Lengkap:
PDFReferensi
Brigden, G., Hewison, C., Varaine, F., & Rich, M. L. (2014). New developments in the treatment of drug-resistant tuberculosis: clinical utility of bedaquiline and delamanid. Infectious Diseases of Poverty, 3(1), 3.
Dheda, K., Gumbo, T., Maartens, G., Dooley, K. E., McNerney, R., Murray, M., et al. (2017). The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis. Lancet Respiratory Medicine, 5(4), 291-360.
Dheda, K., Limberis, J., Pietersen, E., Phelan, J., Esmail, A., Lesosky, M., et al. (2017). Outcomes, infectiousness, and transmission dynamics of patients with extensively drug-resistant tuberculosis and home-based care: a longitudinal cohort study. Lancet Respiratory Medicine, 5(4), 269-281
Esmail, A., Barry, C. E. III, Young, D. B., & Wilkinson, R. J. (2014). The ongoing challenge of latent tuberculosis. Philosophical Transactions of the Royal Society B: Biological Sciences, 369(1645), 20130437.
Floyd, K., Glaziou, P., Houben, R., Sumner, T., White, R. G., & Raviglione, M. (2018). Global tuberculosis targets and milestones set for 2016-2035: definition and rationale. International Journal of Tuberculosis and Lung Disease, 22(7), 679-689.
Katz, D. E. , & E. D. H. (2011). Protein-Energy Malnutrition and Risk of Infection. Annual Review of Nutrition. 121–148.
Lange, C., Abubakar, I., Alffenaar, J. W., Bothamley, G., Caminero, J. A., Carvalho, A. C., et al. (2014). Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement. European Respiratory Journal, 44(1), 23-63.
Lee, M., Lee, J., Carroll, M. W., Choi, H., Min, S., Song, T., Via, L. E., Goldfeder, L. C., Kang, E., Jin, B., Park, H., Kwak, H., Kim, H., Jeon, H.-S., Jeong, I., Joh, J. S., Chen, R. Y., Olivier, K. N., Shaw, P. A., … Barry, C. E. (2012). Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis. New England Journal of Medicine, 367(16), 1508–1518. https://doi.org/10.1056/nejmoa1201964
Mustofa, S., & Antoni, A. (2023). Case Report: Unilateral Secondary Spontaneous Pneumothorax caused by Pulmonary Tuberculosis in a Heavy Smoker. Sriwijaya Journal of Medicine, 6(3), 87–93.
Mustofa, S., Faisal, M. E. P. A., Soemarwoto, R. A. S., Rusmini, H., & Silaen, D. T. (2023). Tuberkulosis Paru Dengan Pneumonia Komunitas, Paraparese Inferior, Dan Penyakit Jantung Koroner: Laporan Kasus. Jurnal Kedokteran Universitas Lampung, 7(1), 18-24.
Mustofa, S., Herdato, M. J. D., Morfi, C. W., Saputra, T. A., Pratama, A., Tria, M., Putranata, N. R., Sanjaya, R. P., & Erumbia, I. A. (2023). Peningkatan Pengetahuan Mengenai Manajemen Tatalaksana Terhadap Pasien Penyakit Paru Obstruktif Kronik (PPOK) dan Tuberkulosis Paru (TB) Pada Fasilitas Kesehatan Tingkat Pertama (FKTP) di Kabupaten Lampung Tengah. JPM (Jurnal Pengabdian Masyakat) Ruwa Jurai, 8(2), 86–90.
Mustofa, S., Megantoro, G. K., Gozali, A., Saputra, T. T., & Sanjaya, R. P. (2023). SINDROM OBSTRUKSI PASCA TUBERKULOSIS DENGAN LULUH LOBUS: LAPORAN KASUS. Jurnal Ilmu Kedokteran dan Kesehatan, 10(7), 2426-2430.
Mustofa, S., Putri, N. S. P. D. L., Togihon, L., Aryana, W. F., Sanjaya, R. P., & Saputra, T. T. (2023). Pengaruh Pemberian Ekstrak Biji Kopi Robusta (Coffea canephora) Lampung terhadap Aktivitas Enzim Katalase Hippocampus Tikus Putih (Rattus norvegicus) Jantan Galur Sprague dawley yang Diinduksi Monosodium Glutamat. MAJORITY, 12(1), 33-42.
Nahid, P., Mase, S. R., Migliori, G. B., Sotgiu, G., Bothamley, G. H., Brozek, J. L., et al. (2019). Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline. American Journal of Respiratory and Critical Care Medicine, 200(10), e93-e142.
Noviyanti, D. W., & Saftarina, F. (2024). Penatalaksanaan Holistik Pasien Perempuan Usia 55 Tahun Dengan Penyakit Paru Obstruktif Kronis (PPOK) dan Riwayat Tuberculosis (TB) Paru melalui Pendekatan Dokter Keluarga di Wilayah Puskesmas Pasar Ambon. Medical Profession Journal of Lampung, 14(7), 1440-1455.
Pontali, E., Visca, D., Centis, R., D'Ambrosio, L., Spanevello, A., Migliori, G. B. (2013). Multi- and extensively drug-resistant tuberculosis: advances in diagnosis and management. Future Microbiology, 8(4), 451-462.
Poty, P. M., Mustofa, S., Kurniawaty, E., & Soleha, T. U. (2024). Mekanisme Kerja & Penggunaan Klinis N-Acetylcystein (NAC) Pada Penyakit Paru & Saluran Napas. Medical Profession Journal of Lampung, 14(5), 912-918.
Singh, V., & Chibale, K. (2021). Strategies to combat multi-drug resistance in tuberculosis. Accounts of chemical research, 54(10), 2361-2376.
Soemarwoto, R. A., Rusmini, H., Messah, A. D. V., Dilangga, P., Wibowo, A., & Mustofa, S. (2024). Role of matrix metalloproteinase-1 (MMP-1) on lung remodelling in post pulmonary tuberculosis squelae.
Syal, R. , et al. (2014). Hematological profile in patients of pulmonary tuberculosis." International Journal of Research in Medical Sciences. 605–607.
Udwadia, Z. F., & Mullerpattan, J. B. (2014). Multidrug-resistant tuberculosis management in India: past, present, and future. Journal of Thoracic Disease, 6(3), 146-154.
World Health Organization. (2022). WHO consolidated guidelines on drug-resistant tuberculosis treatment.
World Health Organization. (2020). Global Tuberculosis Report 2020. Geneva: World Health Organization. Available at: WHO Global TB Report.
Xie, Y. L., Chakravorty, S., Armstrong, D. T., Hall, S. L., Via, L. E., Song, T., et al. (2017). Evaluation of a rapid molecular drug susceptibility test for tuberculosis. New England Journal of Medicine, 377(11), 1043-1054.
Zignol, M., Dean, A. S., Alikhanova, N., Andres, S., Blanc, L., Cirillo, D. M., et al. (2016). Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project. Lancet Infectious Diseases, 16(10), 1185-1192.
DOI: https://doi.org/10.33024/jikk.v12i2.18173
Refbacks
- Saat ini tidak ada refbacks.
##submission.copyrightStatement##
##submission.license.cc.by-nc4.footer##
Pendidikan Dokter Universitas Malahayati Lampung
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.